Other Events ·
Eupraxia to host virtual Analyst Day on EP-104GI for EoE and attend multiple biotech conferences
EPRXEupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals announced that its management team will participate in several upcoming industry events, including the Craig Hallum Biotech Catalyst Virtual Conference, BIO-Europe, Stifel 2026 Healthcare Conference, and the Jefferies Global Healthcare Conference. The company will also host a virtual Analyst Day on November 13, 2026, to discuss its investigational product EP-104GI for Eosinophilic Esophagitis (EoE). These engagements are scheduled between October and November 2026. Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products using its proprietary Diffusphere technology to address therapeutic areas with high unmet medical need.